GlassScriptPhysician profile
Eduardo J Molinary
NPI 1346246063
$10,918.15
in general payments reported to CMS, 2019-2025
51 companies · $1,671 in 2025
The $1,671 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,860 · 2020: $634 · 2021: $714 · 2022: $1,444 · 2023: $1,934 · 2024: $1,661 · 2025: $1,671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,176 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,176.30 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,852.50 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,476.54 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,082.83 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Grifols USA, LLC | $957.29 | 2019-2025 | Prolastin-C Liquid, Xembify |
| Insmed, INC. | $601.49 | 2019-2025 | Arikayce, Brinsupri |
| Amgen INC. | $390.65 | 2019-2025 | Tezspire |
| Harmony Biosciences LLC | $374.61 | 2023-2025 | Wakix |
| Genzyme Corporation | $351.38 | 2019-2025 | |
| Inspire Medical Systems, INC. | $245.30 | 2024-2025 | Inspire |
| Sunovion Pharmaceuticals INC. | $239.96 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $220.88 | 2019-2025 | |
| Verona Pharma, INC. | $158.53 | 2025 | Ohtuvayre |
| Janssen Pharmaceuticals, INC | $136.28 | 2019 | |
| Mallinckrodt Enterprises LLC | $134.30 | 2019 | |
| Csa Medical, INC | $133.57 | 2019 |
Show all 51 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $130.79 | 2022-2024 | Glassia |
| Ascensia Diabetes Care US INC. | $111.67 | 2023 | |
| Pulmonx Corporation | $111.39 | 2023-2024 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
| Pfizer INC. | $83.80 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $80.23 | 2021-2025 | Dupixent |
| Mallinckrodt Hospital Products INC. | $78.16 | 2020-2024 | Acthar |
| Actelion Pharmaceuticals US, INC. | $74.97 | 2019-2023 | Uptravi |
| Ani Pharmaceuticals, INC. | $66.08 | 2023 | Purified Cortrophin Gel |
| Avadel Cns Pharmaceuticals, LLC | $61.35 | 2024-2025 | Lumryz |
| Genentech USA, INC. | $54.08 | 2019-2022 | |
| Electromed, INC. | $52.03 | 2019-2022 | |
| Mylan Specialty L.P. | $48.21 | 2019-2023 | Yupelri |
| 3b Medical, INC. | $47.11 | 2024 | Luna |
| Baxter Healthcare | $45.66 | 2023-2024 | Hillrom - Vest System Model 105 Home Care |
| Vapotherm INC | $42.32 | 2022 | |
| Gilead Sciences, INC. | $38.99 | 2022-2023 | |
| Allergan, INC. | $35.70 | 2019-2020 | |
| United Therapeutics Corporation | $35.05 | 2019-2021 | |
| Resmed Corp | $30.40 | 2023 | |
| Philips North America LLC | $29.96 | 2022 | |
| Axsome Therapeutics, INC. | $29.75 | 2024 | Sunosi |
| Abbvie INC. | $28.50 | 2023 | |
| Stryker Corporation | $22.19 | 2025 | Flowtriever |
| E.R. Squibb & Sons, L.L.C. | $21.70 | 2025 | Camzyos |
| Advanced Respiratory, INC | $20.26 | 2021 | |
| Viatris Specialty LLC | $19.81 | 2025 | Yupelri |
| Shire North American Group INC | $19.50 | 2019 | |
| Lilly USA, LLC | $17.97 | 2025 | Zepbound |
| Taiho Oncology, INC. | $17.37 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $17.29 | 2022 | |
| La Jolla Pharmaceutical Company | $17.28 | 2019 | |
| Olympus America INC. | $16.34 | 2022 | |
| Alexion Pharmaceuticals, INC. | $15.93 | 2022 | |
| Celgene Corporation | $13.72 | 2021 | |
| Inogen, INC. | $13.44 | 2024 | |
| Circassia INC. | $13.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eduardo Molinary listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.